Astraveus
PrivateLast Round
Grant
Dec 19, 2024
Total Funding Raised
$36.72M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Astraveus operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Grant round in December 2024.
Astraveus is a biotechnology company that develops the Lakhesys™ platform, a benchtop cell factory for the automated and miniaturized manufacturing of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astraveus Comparables
Compare Astraveus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 89% | |
| Limula | 86% | |
| Adva Biotechnology | 85% |
For institutional investors. Book with your work email.
Astraveus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 19, 2024 | ||||
| Grant | Oct 24, 2023 | ||||
| Seed | Jun 27, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Astraveus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Seed |
| Government of France | Grant |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
| Bpifrance | Grant, Seed |
| AdBio partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 1060% MoM, reaching 1.9K.
- Jul 20, 2026
Open roles increased to 31, 2.3x the trailing average.
For institutional investors. Book with your work email.
Astraveus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Astraveus's valuation, stock price, and market status.
Is Astraveus a public or private company?
Astraveus is a private company.
What is the current stock price of Astraveus?
Astraveus is a private company, so its shares have no public market price. Caplight tracks Astraveus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astraveus worth (valuation)?
Valuation information for Astraveus is not publicly available.
Can I buy Astraveus stock?
Astraveus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astraveus's last funding round?
Astraveus's most recent funding round was Grant on December 19, 2024.
Who are the main investors in Astraveus?
Key investors in Astraveus include AdBio partners.
Will Astraveus IPO soon?
No public IPO plans have been announced for Astraveus.
How can I track Astraveus secondary market activity?
Caplight tracks bids, offers, and trades in Astraveus's shares on secondary markets.